{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T02:56:47Z","timestamp":1781146607612,"version":"3.54.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82372900"],"award-info":[{"award-number":["82372900"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82370460"],"award-info":[{"award-number":["82370460"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82471830"],"award-info":[{"award-number":["82471830"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02899-9","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:38:13Z","timestamp":1777336693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytoplasmic retention of IRF3 binding Vimentin competitively with ERK1\/2 mitigates acute myeloid leukemia through TFEB nuclear translocation"],"prefix":"10.1186","volume":"24","author":[{"given":"Manman","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aili","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxia","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanglong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanshuo","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shemin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"5","key":"2899_CR1","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.tips.2024.03.005","volume":"45","author":"M Forsberg","year":"2024","unstructured":"Forsberg M, Konopleva M. AML treatment: conventional chemotherapy and emerging novel agents. Trends Pharmacol Sci. 2024;45(5):430\u201348.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"2899_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13045-021-01062-w","volume":"14","author":"H Liu","year":"2021","unstructured":"Liu H. Emerging agents and regimens for AML. J Hematol Oncol. 2021;14(1):49.","journal-title":"J Hematol Oncol"},{"issue":"12","key":"2899_CR3","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.3324\/haematol.2021.278984","volume":"106","author":"M Levis","year":"2021","unstructured":"Levis M. Arsenic and all-trans retinoic acid for acute promyelocytic leukemia: yes, it really is as good as it seems. Haematologica. 2021;106(12):3031\u20132.","journal-title":"Haematologica"},{"issue":"1","key":"2899_CR4","first-page":"26","volume":"106","author":"V Madan","year":"2021","unstructured":"Madan V, Koeffler HP. Differentiation therapy of myeloid leukemia: four decades of development. Haematologica. 2021;106(1):26\u201338.","journal-title":"Haematologica"},{"issue":"12","key":"2899_CR5","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1182\/blood.2024024008","volume":"145","author":"GC Issa","year":"2025","unstructured":"Issa GC, Stein EM, DiNardo CD. How I treat acute myeloid leukemia with differentiation therapy. Blood. 2025;145(12):1251\u20139.","journal-title":"Blood"},{"issue":"7","key":"2899_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1182\/blood.2019002140","volume":"135","author":"GJ Roboz","year":"2020","unstructured":"Roboz GJ, DiNardo CD, Stein EM, de Botton S, Mims AS, Prince GT, et al. Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia. Blood. 2020;135(7):463\u201371.","journal-title":"Blood"},{"issue":"13","key":"2899_CR7","doi-asserted-by":"publisher","first-page":"11254","DOI":"10.1021\/acs.jmedchem.4c00809","volume":"67","author":"LG DeRatt","year":"2024","unstructured":"DeRatt LG, Zhang Z, Pietsch C, Cisar JS, Zhang X, Wang W, et al. Discovery of JNJ-74856665: a novel isoquinolinone DHODH inhibitor for the treatment of AML. J Med Chem. 2024;67(13):11254\u201372.","journal-title":"J Med Chem"},{"issue":"5","key":"2899_CR8","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00277-023-05156-y","volume":"102","author":"H Zhuang","year":"2023","unstructured":"Zhuang H, Li F, Xu Y, Pei R, Chen D, Liu X, et al. Loss of IRF8 inhibits the growth of acute myeloid leukemia cells. Ann Hematol. 2023;102(5):1063\u201372.","journal-title":"Ann Hematol"},{"issue":"8067","key":"2899_CR9","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-025-08915-1","volume":"642","author":"A Hosseini","year":"2025","unstructured":"Hosseini A, Dhall A, Ikonen N, Sikora N, Nguyen S, Shen Y, et al. Perturbing LSD1 and WNT rewires transcription to synergistically induce AML differentiation. Nature. 2025;642(8067):508\u201318.","journal-title":"Nature"},{"issue":"1","key":"2899_CR10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41392-024-01980-4","volume":"9","author":"L Wang","year":"2024","unstructured":"Wang L, Zhu Y, Zhang N, Xian Y, Tang Y, Ye J, et al. The multiple roles of interferon regulatory factor family in health and disease. Signal Transduct Target Ther. 2024;9(1):282.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2899_CR11","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/s41467-024-45916-6","volume":"15","author":"B Wang","year":"2024","unstructured":"Wang B, Reville PK, Yassouf MY, Jelloul FZ, Ly C, Desai PN, et al. Comprehensive characterization of IFNgamma signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies. Nat Commun. 2024;15(1):1821.","journal-title":"Nat Commun"},{"issue":"17","key":"2899_CR12","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.3390\/cells11172630","volume":"11","author":"HR Moorman","year":"2022","unstructured":"Moorman HR, Reategui Y, Poschel DB, Liu K. IRF8: mechanism of action and health implications. Cells. 2022;11(17):2630.","journal-title":"Cells"},{"issue":"3","key":"2899_CR13","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.bbrc.2016.08.080","volume":"478","author":"WL Tian","year":"2016","unstructured":"Tian WL, Jiang ZX, Wang F, Guo R, Tang P, Huang YM, et al. IRF3 is involved in human acute myeloid leukemia through regulating the expression of miR-155. Biochem Biophys Res Commun. 2016;478(3):1130\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2899_CR14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00262-009-0804-6","volume":"59","author":"D Savitsky","year":"2010","unstructured":"Savitsky D, Tamura T, Yanai H, Taniguchi T. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol Immunother. 2010;59(4):489\u2013510.","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"2899_CR15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3324\/haematol.2020.274480","volume":"107","author":"K Ponnusamy","year":"2022","unstructured":"Ponnusamy K, Tzioni MM, Begum M, Robinson ME, Caputo VS, Katsarou A, et al. The innate sensor ZBP1-IRF3 axis regulates cell proliferation in multiple myeloma. Haematologica. 2022;107(3):721\u201332.","journal-title":"Haematologica"},{"issue":"37","key":"2899_CR16","doi-asserted-by":"publisher","first-page":"e2121385119","DOI":"10.1073\/pnas.2121385119","volume":"119","author":"S Popli","year":"2022","unstructured":"Popli S, Chakravarty S, Fan S, Glanz A, Aras S, Nagy LE, et al. IRF3 inhibits nuclear translocation of NF-kappaB to prevent viral inflammation. Proc Natl Acad Sci U S A. 2022;119(37):e2121385119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"656","key":"2899_CR17","doi-asserted-by":"publisher","first-page":"eabn7571","DOI":"10.1126\/scitranslmed.abn7571","volume":"14","author":"EM Grasset","year":"2022","unstructured":"Grasset EM, Dunworth M, Sharma G, Loth M, Tandurella J, Cimino-Mathews A, et al. Triple-negative breast cancer metastasis involves complex epithelial-mesenchymal transition dynamics and requires vimentin. Sci Transl Med. 2022;14(656):eabn7571.","journal-title":"Sci Transl Med."},{"issue":"1","key":"2899_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12967-018-1539-y","volume":"16","author":"S Wu","year":"2018","unstructured":"Wu S, Du Y, Beckford J, Alachkar H. Upregulation of the EMT marker vimentin is associated with poor clinical outcome in acute myeloid leukemia. J Transl Med. 2018;16(1):170.","journal-title":"J Transl Med"},{"issue":"1","key":"2899_CR19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s13046-023-02860-5","volume":"42","author":"WM Hu","year":"2023","unstructured":"Hu WM, Li M, Ning JZ, Tang YQ, Song TB, Li LZ, et al. FAM171B stabilizes vimentin and enhances CCL2-mediated TAM infiltration to promote bladder cancer progression. J Exp Clin Cancer Res. 2023;42(1):290.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"2899_CR20","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","volume":"21","author":"H Lavoie","year":"2020","unstructured":"Lavoie H, Gagnon J, Therrien M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol. 2020;21(10):607\u201332.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6036","key":"2899_CR21","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.1204592","volume":"332","author":"C Settembre","year":"2011","unstructured":"Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, et al. TFEB links autophagy to lysosomal biogenesis. Science. 2011;332(6036):1429\u201333.","journal-title":"Science"},{"issue":"7948","key":"2899_CR22","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41586-022-05652-7","volume":"614","author":"Z Cui","year":"2023","unstructured":"Cui Z, Napolitano G, de Araujo MEG, Esposito A, Monfregola J, Huber LA, et al. Structure of the lysosomal mTORC1-TFEB-Rag-Ragulator megacomplex. Nature. 2023;614(7948):572\u20139.","journal-title":"Nature"},{"issue":"6","key":"2899_CR23","doi-asserted-by":"publisher","first-page":"700","DOI":"10.15252\/embr.201439496","volume":"16","author":"T Yonekawa","year":"2015","unstructured":"Yonekawa T, Gamez G, Kim J, Tan AC, Thorburn J, Gump J, et al. RIP1 negatively regulates basal autophagic flux through TFEB to control sensitivity to apoptosis. EMBO Rep. 2015;16(6):700\u20138.","journal-title":"EMBO Rep"},{"issue":"2","key":"2899_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1158\/2643-3230.BCD-20-0029","volume":"2","author":"S Yun","year":"2021","unstructured":"Yun S, Vincelette ND, Yu X, Watson GW, Fernandez MR, Yang C, et al. TFEB links MYC signaling to epigenetic control of myeloid differentiation and acute myeloid leukemia. Blood Cancer Discov. 2021;2(2):162\u201385.","journal-title":"Blood Cancer Discov"},{"issue":"2","key":"2899_CR25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s12010-016-2242-1","volume":"181","author":"J Xu","year":"2017","unstructured":"Xu J, Zhu W, Guo Y, Jiang C, Hussain N, Meng L, et al. Construction of conveniently Screening pLKO.1-TRC vector tagged with TurboGFP. Appl Biochem Biotechnol. 2017;181(2):699\u2013709.","journal-title":"Appl Biochem Biotechnol."},{"key":"2899_CR26","doi-asserted-by":"publisher","first-page":"108579","DOI":"10.1016\/j.clim.2020.108579","volume":"220","author":"M Geng","year":"2020","unstructured":"Geng M, Xu K, Meng L, Xu J, Jiang C, Guo Y, et al. Up-regulated DERL3 in fibroblast-like synoviocytes exacerbates inflammation of rheumatoid arthritis. Clin Immunol. 2020;220:108579.","journal-title":"Clin Immunol"},{"issue":"24","key":"2899_CR27","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1182\/blood-2017-10-813139","volume":"131","author":"M Ying","year":"2018","unstructured":"Ying M, Shao X, Jing H, Liu Y, Qi X, Cao J, et al. Ubiquitin-dependent degradation of CDK2 drives the therapeutic differentiation of AML by targeting PRDX2. Blood. 2018;131(24):2698\u2013711.","journal-title":"Blood"},{"issue":"1","key":"2899_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4049\/jimmunol.1500232","volume":"195","author":"M Zhu","year":"2015","unstructured":"Zhu M, Fang T, Li S, Meng K, Guo D. Bipartite nuclear localization signal controls nuclear import and DNA-binding activity of IFN regulatory factor 3. J Immunol. 2015;195(1):289\u201397.","journal-title":"J Immunol"},{"issue":"6181","key":"2899_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1126\/science.1251456","volume":"344","author":"P Wang","year":"2014","unstructured":"Wang P, Xue Y, Han Y, Lin L, Wu C, Xu S, et al. The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation. Science. 2014;344(6181):310\u20133.","journal-title":"Science"},{"issue":"1","key":"2899_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cell.2016.08.057","volume":"167","author":"DB Sykes","year":"2016","unstructured":"Sykes DB, Kfoury YS, Mercier FE, Wawer MJ, Law JM, Haynes MK, et al. Inhibition of dihydroorotate dehydrogenase overcomes differentiation blockade in acute myeloid leukemia. Cell. 2016;167(1):171-86 e15.","journal-title":"Cell"},{"issue":"1","key":"2899_CR31","doi-asserted-by":"publisher","first-page":"7548","DOI":"10.1038\/s41598-024-58301-6","volume":"14","author":"J Zheng","year":"2024","unstructured":"Zheng J, Haseeb A, Wang Z, Wang H. Network pharmacology, computational biology integrated surface plasmon resonance technology reveals the mechanism of ellagic acid against rotavirus. Sci Rep. 2024;14(1):7548.","journal-title":"Sci Rep"},{"issue":"22","key":"2899_CR32","first-page":"2738","volume":"141","author":"V Krishnan","year":"2023","unstructured":"Krishnan V, Schmidt F, Nawaz Z, Venkatesh PN, Lee KL, Ren X, et al. A single-cell atlas identifies pretreatment features of primary imatinib resistance in chronic myeloid leukemia. Blood. 2023;141(22):2738\u201355.","journal-title":"Blood"},{"issue":"7","key":"2899_CR33","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/sj.leu.2403788","volume":"19","author":"GS Sellick","year":"2005","unstructured":"Sellick GS, Spendlove HE, Catovsky D, Pritchard-Jones K, Houlston RS. Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia. Leukemia. 2005;19(7):1276\u20138.","journal-title":"Leukemia"},{"issue":"4","key":"2899_CR34","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.stem.2020.12.005","volume":"28","author":"E Wang","year":"2021","unstructured":"Wang E, Zhou H, Nadorp B, Cayanan G, Chen X, Yeaton AH, et al. Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation. Cell Stem Cell. 2021;28(4):718-31 e6.","journal-title":"Cell Stem Cell"},{"issue":"11","key":"2899_CR35","doi-asserted-by":"publisher","first-page":"9698","DOI":"10.1074\/jbc.M310616200","volume":"279","author":"M Mori","year":"2004","unstructured":"Mori M, Yoneyama M, Ito T, Takahashi K, Inagaki F, Fujita T. Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation. J Biol Chem. 2004;279(11):9698\u2013702.","journal-title":"J Biol Chem"},{"issue":"5","key":"2899_CR36","doi-asserted-by":"publisher","first-page":"e20191174","DOI":"10.1084\/jem.20191174","volume":"217","author":"Z Cai","year":"2020","unstructured":"Cai Z, Zhang MX, Tang Z, Zhang Q, Ye J, Xiong TC, et al. USP22 promotes IRF3 nuclear translocation and antiviral responses by deubiquitinating the importin protein KPNA2. J Exp Med. 2020;217(5):e20191174.","journal-title":"J Exp Med."},{"issue":"794","key":"2899_CR37","doi-asserted-by":"publisher","first-page":"eadj9095","DOI":"10.1126\/scitranslmed.adj9095","volume":"17","author":"T Long","year":"2025","unstructured":"Long T, Lu Y, Ma Y, Song Y, Yi X, Chen X, et al. Condensation of cellular prion protein promotes renal fibrosis through the TBK1-IRF3 signaling axis. Sci Transl Med. 2025;17(794):eadj9095.","journal-title":"Sci Transl Med."},{"issue":"5","key":"2899_CR38","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jmb.2006.09.056","volume":"364","author":"E Perlson","year":"2006","unstructured":"Perlson E, Michaelevski I, Kowalsman N, Ben-Yaakov K, Shaked M, Seger R, et al. Vimentin binding to phosphorylated Erk sterically hinders enzymatic dephosphorylation of the kinase. J Mol Biol. 2006;364(5):938\u201344.","journal-title":"J Mol Biol"},{"issue":"9","key":"2899_CR39","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1084\/jem.20142274","volume":"212","author":"LL Andersen","year":"2015","unstructured":"Andersen LL, Mork N, Reinert LS, Kofod-Olsen E, Narita R, Jorgensen SE, et al. Functional IRF3 deficiency in a patient with herpes simplex encephalitis. J Exp Med. 2015;212(9):1371\u20139.","journal-title":"J Exp Med"},{"issue":"11","key":"2899_CR40","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1158\/0008-5472.CAN-14-2842","volume":"75","author":"R Virtakoivu","year":"2015","unstructured":"Virtakoivu R, Mai A, Mattila E, De Franceschi N, Imanishi SY, Corthals G, et al. Vimentin-ERK signaling uncouples slug gene regulatory function. Cancer Res. 2015;75(11):2349\u201362.","journal-title":"Cancer Res"},{"issue":"2","key":"2899_CR41","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41375-019-0552-3","volume":"34","author":"E Weisberg","year":"2020","unstructured":"Weisberg E, Meng C, Case A, Sattler M, Tiv HL, Gokhale PC, et al. Evaluation of ERK as a therapeutic target in acute myelogenous leukemia. Leukemia. 2020;34(2):625\u20139.","journal-title":"Leukemia"},{"issue":"3","key":"2899_CR42","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/ncb3114","volume":"17","author":"DL Medina","year":"2015","unstructured":"Medina DL, Di Paola S, Peluso I, Armani A, De Stefani D, Venditti R, et al. Lysosomal calcium signalling regulates autophagy through calcineurin and \u200bTFEB. Nat Cell Biol. 2015;17(3):288\u201399.","journal-title":"Nat Cell Biol"},{"issue":"49","key":"2899_CR43","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1038\/onc.2015.50","volume":"34","author":"A de Laurentiis","year":"2015","unstructured":"de Laurentiis A, Hiscott J, Alcalay M. The TEL-AML1 fusion protein of acute lymphoblastic leukemia modulates IRF3 activity during early B-cell differentiation. Oncogene. 2015;34(49):6018\u201328.","journal-title":"Oncogene"},{"issue":"37","key":"2899_CR44","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.2217\/fon-2023-0443","volume":"19","author":"J Zeng","year":"2023","unstructured":"Zeng J, Yao J, Zhou Y, Yu L, Zhang L, Wang C, et al. Expression of interferon regulatory factor family and its prognostic value in acute myeloid leukemia. Future Oncol. 2023;19(37):2465\u201379.","journal-title":"Future Oncol"},{"issue":"1","key":"2899_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13046-022-02352-y","volume":"41","author":"AP Runde","year":"2022","unstructured":"Runde AP, Mack R, SJ PB, Zhang J. The role of TBK1 in cancer pathogenesis and anticancer immunity. J Exp Clin Cancer Res. 2022;41(1):135.","journal-title":"J Exp Clin Cancer Res."},{"issue":"1","key":"2899_CR46","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1038\/s41467-022-30240-8","volume":"13","author":"R Wang","year":"2022","unstructured":"Wang R, Yang X, Liu J, Zhong F, Zhang C, Chen Y, et al. Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate. Nat Commun. 2022;13(1):2522.","journal-title":"Nat Commun"},{"issue":"48","key":"2899_CR47","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1038\/s41388-022-02505-5","volume":"41","author":"LM Lee","year":"2022","unstructured":"Lee LM, Christodoulou EG, Shyamsunder P, Chen BJ, Lee KL, Fung TK, et al. A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify((R)). Oncogene. 2022;41(48):5160\u201375.","journal-title":"Oncogene"},{"issue":"27","key":"2899_CR48","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1038\/sj.onc.1202802","volume":"18","author":"L Pelicano","year":"1999","unstructured":"Pelicano L, Brumpt C, Pitha PM, Chelbi-Alix MK. Retinoic acid resistance in NB4 APL cells is associated with lack of interferon alpha synthesis Stat1 and p48 induction. Oncogene. 1999;18(27):3944\u201353.","journal-title":"Oncogene"},{"issue":"6","key":"2899_CR49","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/ni1347","volume":"7","author":"T Saitoh","year":"2006","unstructured":"Saitoh T, Tun-Kyi A, Ryo A, Yamamoto M, Finn G, Fujita T, et al. Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat Immunol. 2006;7(6):598\u2013605.","journal-title":"Nat Immunol"},{"issue":"10","key":"2899_CR50","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1080\/15548627.2022.2026098","volume":"18","author":"W Xie","year":"2022","unstructured":"Xie W, Tian S, Yang J, Cai S, Jin S, Zhou T, et al. OTUD7B deubiquitinates SQSTM1\/p62 and promotes IRF3 degradation to regulate antiviral immunity. Autophagy. 2022;18(10):2288\u2013302.","journal-title":"Autophagy"},{"key":"2899_CR51","doi-asserted-by":"publisher","first-page":"216836","DOI":"10.1016\/j.canlet.2024.216836","volume":"589","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Li H, Zhang Y, Zhao E, Huang C, Pan X, et al. Deubiquitinase USP4 suppresses antitumor immunity by inhibiting IRF3 activation and tumor cell-intrinsic interferon response in colorectal cancer. Cancer Lett. 2024;589:216836.","journal-title":"Cancer Lett"},{"issue":"3","key":"2899_CR52","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/ni.3311","volume":"17","author":"S Li","year":"2016","unstructured":"Li S, Zhu M, Pan R, Fang T, Cao YY, Chen S, et al. The tumor suppressor PTEN has a critical role in antiviral innate immunity. Nat Immunol. 2016;17(3):241\u20139.","journal-title":"Nat Immunol"},{"issue":"1","key":"2899_CR53","doi-asserted-by":"publisher","first-page":"5762","DOI":"10.1038\/s41467-020-19627-7","volume":"11","author":"M Tian","year":"2020","unstructured":"Tian M, Wang X, Sun J, Lin W, Chen L, Liu S, et al. IRF3 prevents colorectal tumorigenesis via inhibiting the nuclear translocation of beta-catenin. Nat Commun. 2020;11(1):5762.","journal-title":"Nat Commun"},{"issue":"2","key":"2899_CR54","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1084\/jem.20171116","volume":"215","author":"S Jiao","year":"2018","unstructured":"Jiao S, Guan J, Chen M, Wang W, Li C, Wang Y, et al. Targeting IRF3 as a YAP agonist therapy against gastric cancer. J Exp Med. 2018;215(2):699\u2013718.","journal-title":"J Exp Med"},{"issue":"7-8","key":"2899_CR55","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1101\/gad.349358.122","volume":"36","author":"KM Ridge","year":"2022","unstructured":"Ridge KM, Eriksson JE, Pekny M, Goldman RD. Roles of vimentin in health and disease. Genes Dev. 2022;36(7\u20138):391\u2013407.","journal-title":"Genes Dev"},{"key":"2899_CR56","doi-asserted-by":"publisher","first-page":"106818","DOI":"10.1016\/j.phrs.2023.106818","volume":"193","author":"W Wang","year":"2023","unstructured":"Wang W, Zhu L, Zhou J, Liu X, Xiao M, Chen N, et al. Targeting the KRT16-vimentin axis for metastasis in lung cancer. Pharmacol Res. 2023;193:106818.","journal-title":"Pharmacol Res"},{"issue":"Supplement 1","key":"2899_CR57","doi-asserted-by":"publisher","first-page":"6260","DOI":"10.1182\/blood-2022-163664","volume":"140","author":"S Hubner","year":"2022","unstructured":"Hubner S, Konopleva M, Zeng Z, Hoff FW, Qiu Y, Ruvolo V, et al. Targeting vimentin (VIM) in acute myelogenous leukemia (AML). Blood. 2022;140(Supplement 1):6260\u20131.","journal-title":"Blood"},{"issue":"13","key":"2899_CR58","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.3390\/molecules27134190","volume":"27","author":"Z Gong","year":"2022","unstructured":"Gong Z, Gao X, Yang Q, Lun J, Xiao H, Zhong J, et al. Phosphorylation of ERK-Dependent NF-kappaB Triggers NLRP3 Inflammasome Mediated by Vimentin in EV71-Infected Glioblastoma Cells. Molecules. 2022;27(13):4190.","journal-title":"Molecules"},{"issue":"10","key":"2899_CR59","doi-asserted-by":"publisher","first-page":"107729","DOI":"10.1016\/j.jbc.2024.107729","volume":"300","author":"Y Duan","year":"2024","unstructured":"Duan Y, Liu S, Wang J, Yang K, Xu J, Wang Q, et al. Overexpression of RBM4 promotes acute myeloid leukemia cell differentiation by regulating alternative splicing of TFEB. J Biol Chem. 2024;300(10):107729.","journal-title":"J Biol Chem"},{"issue":"8","key":"2899_CR60","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/s41418-022-01028-6","volume":"29","author":"A Tan","year":"2022","unstructured":"Tan A, Prasad R, Lee C, Jho EH. Past, present, and future perspectives of transcription factor EB (TFEB): mechanisms of regulation and association with disease. Cell Death Differ. 2022;29(8):1433\u201349.","journal-title":"Cell Death Differ"},{"issue":"6","key":"2899_CR61","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1007\/s00204-025-04030-2","volume":"99","author":"X Liu","year":"2025","unstructured":"Liu X, Zhang X, Li X, Zhang C, Cai H, Qi J, et al. Dihydromyricetin restores lysosomal function in Schwann cells to alleviate bortezomib-induced peripheral neuropathy via ERK\/TFEB signaling. Arch Toxicol. 2025;99(6):2639\u201353.","journal-title":"Arch Toxicol."},{"issue":"5","key":"2899_CR62","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/emboj.2012.32","volume":"31","author":"C Settembre","year":"2012","unstructured":"Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Erdin S, et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 2012;31(5):1095\u2013108.","journal-title":"EMBO J"},{"issue":"11","key":"2899_CR63","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1038\/s41380-022-01713-5","volume":"27","author":"YS Chun","year":"2022","unstructured":"Chun YS, Kim MY, Lee SY, Kim MJ, Hong TJ, Jeon JK, et al. MEK1\/2 inhibition rescues neurodegeneration by TFEB-mediated activation of autophagic lysosomal function in a model of Alzheimer\u2019s Disease. Mol Psychiatry. 2022;27(11):4770\u201380.","journal-title":"Mol Psychiatry"},{"issue":"7","key":"2899_CR64","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1080\/15548627.2015.1054594","volume":"11","author":"Y Tong","year":"2015","unstructured":"Tong Y, Song F. Intracellular calcium signaling regulates autophagy via calcineurin-mediated TFEB dephosphorylation. Autophagy. 2015;11(7):1192\u20135.","journal-title":"Autophagy"},{"issue":"8","key":"2899_CR65","doi-asserted-by":"publisher","first-page":"7180","DOI":"10.3390\/ijms24087180","volume":"24","author":"M Opydo","year":"2023","unstructured":"Opydo M, Mlyczynska A, Mlyczynska E, Rak A, Kolaczkowska E. Synergistic action of MCL-1 inhibitor with BCL-2\/BCL-XL or MAPK pathway inhibitors enhances acute myeloid leukemia cell apoptosis and differentiation. Int J Mol Sci. 2023;24(8):7180.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2899_CR66","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/jcp.24513","volume":"229","author":"X Wang","year":"2014","unstructured":"Wang X, Pesakhov S, Harrison JS, Danilenko M, Studzinski GP. ERK5 pathway regulates transcription factors important for monocytic differentiation of human myeloid leukemia cells. J Cell Physiol. 2014;229(7):856\u201367.","journal-title":"J Cell Physiol"},{"issue":"8","key":"2899_CR67","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1038\/s41418-021-00768-1","volume":"28","author":"M Humbert","year":"2021","unstructured":"Humbert M, Seiler K, Mosimann S, Rentsch V, Sharma K, Pandey AV, et al. Reducing FASN expression sensitizes acute myeloid leukemia cells to differentiation therapy. Cell Death Differ. 2021;28(8):2465\u201381.","journal-title":"Cell Death Differ"},{"issue":"2","key":"2899_CR68","doi-asserted-by":"publisher","first-page":"e55472","DOI":"10.15252\/embr.202255472","volume":"24","author":"JA Martina","year":"2023","unstructured":"Martina JA, Jeong E, Puertollano R. p38 MAPK-dependent phosphorylation of TFEB promotes monocyte-to-macrophage differentiation. EMBO Rep. 2023;24(2):e55472.","journal-title":"EMBO Rep"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02899-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02899-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02899-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T02:01:53Z","timestamp":1781143313000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02899-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2899"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02899-9","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"347"}}